Title Credit Typesort ascending Event date Cost
The Age of Disease Modification in Alzheimer’s Disease: A Grand Rounds Series on the Practical Implementation of Amyloid Targeting Therapies into...
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Attendance
Live 06/19/2025 - 1:00pm EDT $0.00
The Path to Least Resistance: The Emerging Role of Noncovalent BTK Inhibitors in CLL/SLL Across Clinical Practice Settings
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 AAPA Category I CME
Enduring $0.00
Lost in Transition: Pearls From An Interactive Workshop to Improve the Journey to Adulthood in Spinal Muscular Atrophy
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 AAPA Category I CME
    • 0.50 Attendance
Enduring $0.00
Broadening the Treatment Horizon: Examining the Expanding Roles of New Therapies in Epilepsy Management (Credit Expired) Enduring $0.00
The Frontline of Alzheimer's Care: Addressing Real Questions from Clinicians in the New Dawn of Disease-Modifying Therapy Enduring $0.00
Stronger Together: Leveraging Evidence-Based Patient Collaboration and Treatment Strategies to Streamline Success in Multiple Sclerosis Enduring $0.00
Following a Moving Target: Current and Emerging Strategies for the Prevention and Management of COVID-19 in Patients with Multiple Sclerosis Enduring $0.00
Individualizing Narcolepsy: Using Clinical Evidence and Patient Factors to Improve Diagnosis and Optimize Therapeutic Management Enduring $0.00
When the Default is Not Enough: An Emergency Medicine Clinician's Guide to Novel Amyloid-Related Imaging Abnormalities in Alzheimer's... Enduring $0.00
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum Enduring $0.00
Unlocking the Alzheimer’s Brain: How Radiological Tools and Biomarkers Hold the Key to Early Diagnosis and Decision-Making Enduring $0.00
On the Clinic Floor: Addressing the Most Critical Questions of Frontline Clinicians in Multiple Sclerosis Management Enduring $0.00
Questions from the Community: Examining the Application of Recent Research Advances into the Management of Patients with HR-Positive/HER2-Negative...
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 Attendance
Enduring $0.00
The ARIA Toolkit: An Interdisciplinary Curriculum to Optimize Team-Based Management of Amyloid-Related Imaging Abnormalities in Alzheimer’s Disease Enduring $0.00
A Bispecific Breakthrough: Addressing Real Clinician Questions on the Practical Application of Bispecific Antibodies Across Practice Settings in...
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ACPE Pharmacy
    • 0.75 Attendance
Enduring $0.00

Pages